University of Cincinnati
Cincinnati, Ohio, 45267-0559, United States
NCT Number: NCT00599508
To evaluate the effect of supplemented berry fruit juice and whole fruit berry powder on memory performance and brain function in older adults
Looking for future studies?
Notify Me66 year and older
All sexes
Interventional
Not applicable
Cincinnati, Ohio, 45267-0559, United States
Randomized trials involving daily supplementation with berry fruits in older adults with early memory changes. The berry products include Concord grape juice, blueberry juice, and whole fruit blueberry powder. Supplementation periods are 12 and 16 weeks, depending on berry product. The Aims of the studies are to assess effects on cognitive performance and in a subset of participants, in brain activity.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Several ounces Concord grape juice administered 3 times a day for 12 or 16 weeks. Specific dosage determined by participant's weight.
Other names: Welch's Concord Grape Juice
several ounces placebo juice consumed three times a day for 12 or 16 weeks; dosage determined according to participant's weight
wild blueberry juice administered daily for 12 weeks, dosage determined according to participant's weight
whole fruit, freeze dried blueberry powder derived from a blend of cultivated blueberries administered daily for 16 weeks
berry placebo powder administered daily for 16 weeks
Time frame: at the end of the intervention
Time frame: at the end of the intervention
University of Cincinnati
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05980286
Aging, Cognition Disorders
San Francisco, California, United States
View Trial DetailsNCT05455229
Behavior, Cognitive Aging
Leuven, Vlaams-Brabant, Belgium
View Trial DetailsNCT02977819
Cognitive Aging
Caen, Calvados, France
View Trial DetailsNCT05672771
Cognitive Aging
Urbana, Illinois, United States
View Trial Details